ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 447

The Influence of Risk Presentation Format on Willingness to Start a Medication

Raluca Cozmuta1, Evan Wilhelms2, Valerie Reyna3, Julia Nolte3 and Liana Fraenkel4, 1Emory University School of Medicine, Atlanta, GA, 2Vasser College, Poughkeepsie, NY, 3Cornell University, Ithica, NY, 4Yale University School of Medicine, New Haven, CT

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: patient preferences

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Quality Measures and Quality of Care - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with rheumatoid arthritis frequently refuse to escalate care because they overweight the probability of adverse events. Effectively communicating risk information to patients is difficult. Several approaches have been developed to facilitate comparative risks; however, recent data suggest that current approaches have a limited impact on risk perceptions and willingness to take medication. The objective of this study was to examine whether an icon array (IA), an illustration of the gist of how medications regulate the immune system (a series of balance beams), or both influence willingness to start a medication.

Methods: Patients with a rheumatic disease were mailed a survey in which they were asked to imagine that their symptoms had worsened and that their physician was recommending a new medication. We varied the probability of an adverse event (pneumonia requiring hospitalization): 2% or 0.2%, and the risk presentation format: numbers, numbers + IA, numbers + balance beams (BB), or numbers + both. Route of administration, benefit, and cost were held constant. Each subject responded to a single, randomly-assigned scenario. We controlled for socioeconomic status (SES), using a variable including both difficulty paying for medications as well as education, in a full-factorial model testing willingness to take the medication (measured on a 5-point scale).

Results: Of 1453 surveys, 465 patients completed the survey. Overall, the mean (SD) age was 59.0 (14.8); 79.7% were female; 83.2% White and 39.1% were classified as having low SES. There were no statistical differences in patient characteristics across the risk presentation formats. Willingness to start the medication was predicted by the interaction between the risk presentation format and SES (F = 2.9, p = 0.03). Willingness by SES status is described in the Figure 1. Among low SES subjects, addition of an IA did not affect willingness compared to the numbers-only format. In contrast, addition of BB (mean difference = 0.47, p = 0.07), or both IA and BB increased willingness (mean difference = 0.48, p = 0.04). Among high SES subjects, addition of an IA or BB or both did not influence willingness compared to the numbers only format. However, both formats including an IA increased willingness compared to the BB format among high SES subjects (mean difference IA vs BB= 0.53, p =0.01; mean difference IA vs IA + BB = 0.48, p = 0.02).

Conclusion: SES affects how subjects respond to risk presentation formats. IA marginally increases willingness in high SES subjects, while BB increases willingness in low SES subjects; when both IA and BB are present, SES differences disappear. BB, when not accompanied by an IA, may decrease willingness in high SES subjects. These results demonstrate the differential effects of risk presentation formats, and highlight the need to identify mechanisms underlying their effects when implementing decision-support tools.  


Disclosure: R. Cozmuta, None; E. Wilhelms, None; V. Reyna, None; J. Nolte, None; L. Fraenkel, None.

To cite this abstract in AMA style:

Cozmuta R, Wilhelms E, Reyna V, Nolte J, Fraenkel L. The Influence of Risk Presentation Format on Willingness to Start a Medication [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-influence-of-risk-presentation-format-on-willingness-to-start-a-medication/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-influence-of-risk-presentation-format-on-willingness-to-start-a-medication/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology